Related Experiment Video
Updated: Apr 14, 2026
05:05
A Modified Precipitation Method to Isolate Urinary Exosomes
Published on: January 16, 2015
18.2K
Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKD
Tim Lange1, Luzia Maron1, Stefan Simm2,3
1Department of Anatomy and Cell Biology, University Medicine Greifswald, 17487 Greifswald, Germany.
Cells
|April 13, 2026
Summary
Urinary exosomal microRNAs (miRNAs) can detect podocyte injury in chronic kidney disease (CKD). This study identifies specific miRNA signatures for different CKD types, aiding early diagnosis and intervention.
Area of Science:
- Nephrology
- Molecular Biology
- Biomarker Discovery
Background:
- Chronic kidney disease (CKD) poses a global health challenge, often involving podocyte damage and loss of kidney function.
- Early detection of podocyte injury is critical for managing CKD but current methods are limited.
- Non-invasive biomarkers are needed for timely diagnosis and intervention in podocytopathies.
Purpose of the Study:
- To analyze urinary exosomal microRNAs (miRNAs) in relation to podocyte morphology in CKD patients.
- To identify specific miRNA profiles associated with different types of podocytopathies, such as focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).
- To correlate miRNA expression with structural podocyte damage and clinical parameters like proteinuria.
Main Methods:
- Analysis of urinary exosomal miRNAs from 65 CKD patients and healthy controls.
- Global miRNA profiling to distinguish CKD patients from controls and identify disease-specific signatures.
- Super-resolution morphometry of kidney biopsies to assess podocyte structure.
- Regression analyses to link miRNA levels with morphometric and clinical data.
Main Results:
- Urinary exosomal miRNA profiling distinguished CKD patients from controls, with specific miRNAs (e.g., miR-606, miR-431) showing altered expression.
- Distinct miRNA profiles were observed in FSGS (elevated miR-181c, miR-3610, etc.) and MCD (suppressed miR-141, miR-429, etc.).
- miRNA levels correlated with filtration slit density, proteinuria, and vitamin D levels, integrating molecular, structural, and clinical data.
Conclusions:
- A coherent miRNA signature of podocyte injury can differentiate CKD entities and reflect disease severity.
- Urinary exosomal miRNAs, combined with morphometric analysis, offer a promising approach for early, non-invasive detection of podocyte damage.
- This approach may enable earlier therapeutic interventions in patients with podocytopathies.
